[go: up one dir, main page]

DK1036566T3 - Tilberedning til kontinuert intravenös administrering - Google Patents

Tilberedning til kontinuert intravenös administrering

Info

Publication number
DK1036566T3
DK1036566T3 DK98957162T DK98957162T DK1036566T3 DK 1036566 T3 DK1036566 T3 DK 1036566T3 DK 98957162 T DK98957162 T DK 98957162T DK 98957162 T DK98957162 T DK 98957162T DK 1036566 T3 DK1036566 T3 DK 1036566T3
Authority
DK
Denmark
Prior art keywords
preparation
intravenous administration
continuous intravenous
administration
hgf
Prior art date
Application number
DK98957162T
Other languages
Danish (da)
English (en)
Inventor
Naoki Yamazaki
Tomokazu Nagano
Ikue Mori
Michitoshi Sekine
Original Assignee
Nakamura Toshikazu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nakamura Toshikazu filed Critical Nakamura Toshikazu
Application granted granted Critical
Publication of DK1036566T3 publication Critical patent/DK1036566T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98957162T 1997-12-03 1998-12-03 Tilberedning til kontinuert intravenös administrering DK1036566T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35012297 1997-12-03
PCT/JP1998/005470 WO1999027951A1 (fr) 1997-12-03 1998-12-03 Preparation pour l'admission intraveineuse continue

Publications (1)

Publication Number Publication Date
DK1036566T3 true DK1036566T3 (da) 2008-01-21

Family

ID=18408389

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98957162T DK1036566T3 (da) 1997-12-03 1998-12-03 Tilberedning til kontinuert intravenös administrering

Country Status (7)

Country Link
US (1) US6869609B1 (fr)
EP (1) EP1036566B1 (fr)
AT (1) ATE372127T1 (fr)
DE (1) DE69838399T2 (fr)
DK (1) DK1036566T3 (fr)
ES (1) ES2289795T3 (fr)
WO (1) WO1999027951A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070142279A1 (en) * 2004-03-09 2007-06-21 Hiroshi Kubo Agent for promoting induction of vascular differentiation, comprising hepatocyte growth factor
EP1852124A4 (fr) * 2005-01-24 2009-08-12 Kringle Pharma Inc Inhibiteur de fibrose pour un organe implante
WO2008102452A1 (fr) 2007-02-22 2008-08-28 Kringle Pharma Inc. Préparation de hgf
CN109535243B (zh) * 2019-01-07 2019-09-24 北京诺思兰德生物技术股份有限公司 人肝细胞生长因子突变体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2750372B2 (ja) * 1990-06-19 1998-05-13 敏一 中村 賢疾患治療剤
US5360790A (en) * 1990-12-11 1994-11-01 The Regents Of The University Of Michigan Method and formulations for the therapy of acute renal failure
JPH08501314A (ja) * 1992-09-16 1996-02-13 ジェネンテク，インコーポレイテッド Ｈｇｆによる肝臓障害に対する保護
AU7389496A (en) * 1995-10-05 1997-04-28 Genentech Inc. Methods and compositions for treating vascular stenosis
EP0979097B1 (fr) * 1997-03-15 2005-11-02 Nakamura, Toshikazu Hgf pour traiter l'insuffisance renale aigue

Also Published As

Publication number Publication date
ES2289795T3 (es) 2008-02-01
EP1036566A4 (fr) 2004-11-17
DE69838399D1 (de) 2007-10-18
WO1999027951A1 (fr) 1999-06-10
DE69838399T2 (de) 2008-06-12
EP1036566A1 (fr) 2000-09-20
US6869609B1 (en) 2005-03-22
ATE372127T1 (de) 2007-09-15
EP1036566B1 (fr) 2007-09-05

Similar Documents

Publication Publication Date Title
DK203787D0 (da) Praeparat til nasal administrering
NZ511201A (en) Use of paclitaxel stabilized with albumin for preparing a drug for the treatment of solid tumors and the drug obtained thereby
TW234691B (fr)
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
LU91037I2 (fr) Somatulina autogel
DK1172114T3 (da) Stabile koncentrerede insulinpræparater til pulmonær indgivelse
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
BR9807234B1 (pt) Composição farmacêutica compreendendo um composto tricílico e uma combinação de miristrato de isopropila e sebacato de dietila, com estabilidade e absorbilidade aumentadas e um pontencial de irritação reduzido
FR2689396B1 (fr) Piégeur d'oxygène actif.
DZ2503A1 (fr) Formulation pure injectable d'un composé anesthésique.
ATE173627T1 (de) Medizinische zusammensetzung
ITTO981046A0 (it) Corredo di siringa ed aghi coordinati, per iniezioni, specialmente per anestesia odontoiatrica.
DE69821498D1 (de) Verwendung von amifostin
PT666739E (pt) Solucao intravenosa que diminui a perda de proteina no corpo.
DK1036566T3 (da) Tilberedning til kontinuert intravenös administrering
DK516288A (da) Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater
EP1103269A4 (fr) Preparations destinees a l'administration d'un facteur de croissance des hepatocytes
CY1106882T1 (el) Τροποποιηση βητακυτταρουλινης
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
DE69902925D1 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen
DE69808287D1 (de) Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid
EP0729950A4 (fr) Medicament anti-vih
IL127536A0 (en) Valve and pump for hypodermic administration of medication
TW357092B (en) Transport of solid medicament components
DK1800664T3 (da) Farmaceutiske formuleringer til parenteral indgivelse indeholdende epothilon